During the last few years, non-invasive methods for the detection of
H. pylori infection are increasingly exploited, especially those using the ELISA assays. One important advantage of these non-invasive methods is that discomfort and risk of invasive endoscopy is avoided. Among the non-invasive tests, the stool antigen test ha been approved by the authorities since it distinguishes patients with active infection from the subjects with only the precedence of
H. pylori infection (
28,
29). Several HpSA tests based on polyclonal and monoclonal antibodies against
H. pylori antigens have been developed, which detect the presence of fecal antigens of
H. pylori, however, their diagnostic accuracy is controversial in various geographical regions (
17,
21,
24).
One reason for the presence of discrepancies among the accuracy of these assays may be the presence of significant heterogeneity among
H. pylori strains especially among those from different geographic regions. Another problem may be the occurrence of cross reactivity with other enteric pathogens which produces uncertain results and may be due to non-adjustment of the cut off values. This possibility was excluded in the case of the HpSA assay, presented in this work. Antibody molecules are highly specific for their corresponding antigens, being able to detect one molecule of a protein antigen out of more than 108 similar molecules (
30,
31). This high specificity may be responsible for the high specificity of the tests based on employment of the monoclonal antibodies. However, due to the presence of vast molecular heterogeneity among
H. pylori strains, a monoclonal antibody prepared against a distinct antigenic determinant, would not necessarily recognize a similar one in another strain. Thus, in many cases, the sensitivities of the tests based on monoclonal antibodies are not similar, especially in geographically different regions. This inconvenience could be lower in cases of tests based on polyclonal antibodies, which have the potential to recognize numerous antigenic determinants.
In Iran, various HpSA ELISA imported kits have been tested, however, their accuracy in the Iranian population may not be similar (
3,
20,
32). Using 16
H. pylori positive and 14
H. pylori negative child patients as the gold standard group, a higher sensitivity and specificity was obtained with the Homemade HpSA kit in comparison with the Imported kit (
Table 1). Although the sensitivity and specificity of this imported kit was evaluated as 97.7% and 96.3%, respectively, by the manufacturer, these values were lower in the case of Iranian
H. pylori, suggesting its lower performance in a geographically different region, such as Iran. This is the first report evaluating and comparing the sensitivity and specificity of commercially imported HpSA ELISA kits with an Iranian homemade kit (based on local
H. pylori antigens) for detection of
H. pylori-specific antigens. Presence of significant molecular heterogeneity amongst Iranian and
H. pylori strains from other regions of the world, impose the development of an HpSA ELISA kit by using local antigens. The results of this evaluation have shown that the homemade HpSA kit, compared with the imported kit and biopsy-proven tests may be a valid and reliable method for checking the presence of
H. pylori infection in Iran.